Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
We provide a demonstration in humans of the principle of pharmacometabonomics by showing a clear connection between an individual's metabolic phenotype, in the form of a predose urinary metabolite profile, and the metabolic fate of a standard dose of the widely used analgesic acetaminophen. Predose and postdose urinary metabolite profiles were determined by 1 H NMR spectroscopy. The predose spectra were statistically analyzed in relation to drug metabolite excretion to detect predose biomarkers of drug fate and a human-gut microbiome cometabolite predictor was identified. Thus, we found that individuals having high predose urinary levels of p -cresol sulfate had low postdose urinary ratios of acetaminophen sulfate to acetaminophen glucuronide. We conclude that, in individuals with high bacterially mediated p -cresol generation, competitive O-sulfonation of p -cresol reduces the effective systemic capacity to sulfonate acetaminophen. Given that acetaminophen is such a widely used and seemingly well-understood drug, this finding provides a clear demonstration of the immense potential and power of the pharmacometabonomic approach. However, we expect many other sulfonation reactions to be similarly affected by competition with p -cresol and our finding also has important implications for certain diseases as well as for the variable responses induced by many different drugs and xenobiotics. We propose that assessing the effects of microbiome activity should be an integral part of pharmaceutical development and of personalized health care. Furthermore, we envisage that gut bacterial populations might be deliberately manipulated to improve drug efficacy and to reduce adverse drug reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“As discussed above, the pre-dose levels of p-cresol sulfate were found to be inversely associated with the ratio of acetaminophen sulfate to acetaminophen glucuronide.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, drug toxicities and efficacies greatly vary depending on the individual patient, given both genetic81 and environmental influences (eg, nutrients,82, 83 drug intake,83, 84 gut microbiome85, 86).”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [85]
In the citing paper
“Pre-dose levels of a microbe-related metabolite, p-cresol sulfate, were found to be inversely associated with the ratio of acetaminophen-sulfate to acetaminophen-glucuronide.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Trygg, J., Holmes, E., & Lundstedt, T. (2007) · Journal of Proteome Research · doi:10.1021/pr060594q · Cited by 1,273
Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism
Nicholson, J. K., & Wilson, I. D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1157 · Cited by 1,116
Self-citationGut microorganisms, mammalian metabolism and personalized health care
Nicholson, J. K., Holmes, E., & Wilson, I. D. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1152 · Cited by 945
Self-citationPharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824 · cited 3×
“Recognizing this important limitation of pharmacogenomics, a different approach to personalized drug treatment has recently been proposed wherein predose metabolite profiling would instead be used to predict a subject’s responses to potential drug interventions (9).”
BackgroundMethodSelf-citationStatistical strategies for avoiding false discoveries in metabolomics and related experiments
Broadhurst, D. I., & Kell, D. B. (2007) · Metabolomics · doi:10.1007/s11306-006-0037-z · Cited by 817
Parracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784
Moving towards individualized medicine with pharmacogenomics
Evans, W. E., & Relling, M. V. (2004) · Nature · doi:10.1038/nature02626 · Cited by 768
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Human Sulfotransferases and Their Role in Chemical Metabolism
Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj061 · Cited by 703 · cited 4×
“There are various human sulfotransferases (both cytosolic and membrane-bound), but human cytosolic sulfotransferase SULT1A1, which acts on acetaminophen, has a broad substrate range and is one of the most important sulfotransferases for xenobiotic sulfonation as well as acting on several endogenous substrates (26, 51).”
BackgroundInfluentialClinical application of pharmacogenetics
Spear, B. B., Heath-Chiozzi, M., & Huff, J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01986-4 · Cited by 646
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children
Song, Y., Liu, C., & Finegold, S. M. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.11.6459-6465.2004 · Cited by 556
Clinical Pharmacokinetics of Paracetamol
Forrest, J. A. H., Clements, J. A., & Prescott, L. F. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207020-00001 · Cited by 493
Sulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487 · cited 1×
“Coughtrie MWH (2002) Sulfation through the looking glass—recent advances in sulfotransferase research for the curious.”
BackgroundGut microbiota: a potential new territory for drug targeting
Jia, W., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 475
Self-citationAssociation of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use
Whitcomb, D. C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520230055038 · Cited by 470
Kinetics and metabolism of paracetamol and phenacetin.
Prescott, L. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01812.x · Cited by 454
Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004) · Biomarkers · doi:10.1080/13547500410001668379 · Cited by 451
Self-citationPharmacogenomics: The Inherited Basis for Interindividual Differences in Drug Response
Evans, W. E., & Johnson, J. A. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.9 · Cited by 415
Kinetics of acetaminophen absorption and gastric emptying in man
Clements, J. A., Heading, R. C., Nimmo, W. S., & Prescott, L. F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978244420 · Cited by 369
The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation
Klaassen, C. D., & Boles, J. W. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194521 · Cited by 357
Schepers, E., Meert, N., Glorieux, G., Goeman, J., Van der Eycken, J., & Vanholder, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl584 · Cited by 296
Removal of P-Cresol Sulfate by Hemodialysis
Martinez, A. W., Recht, N. S., Hostetter, T. H., & Meyer, T. W. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030310 · Cited by 262
Autism and gastrointestinal symptoms
Horvath, K., & Perman, J. A. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0071-6 · Cited by 260
Variation in human intestinal microbiota with age
Hopkins, M. J., Sharp, R., & Macfarlane, G. T. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80157-8 · Cited by 254
Formation of Phenolic and Indolic Compounds by Anaerobic Bacteria in the Human Large Intestine
Smith, E. A., & Macfarlane, G. T. (1997) · Microbial Ecology · doi:10.1007/s002489900020 · Cited by 244
Bone, E., Tamm, A., & Hill, M. (1976) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/29.12.1448 · Cited by 234
Sulfation through the looking glass—recent advances in sulfotransferase research for the curious
Coughtrie, M. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500117 · Cited by 201
de Loor, H., Bammens, B., Evenepoel, P., De Preter, V., & Verbeke, K. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050781 · Cited by 186
Nebert, D. W., Zhang, G., & Vesell, E. S. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952864 · Cited by 181
Paracetamol sales and atopic disease in children and adults: an ecological analysis
Newson, R., Shaheen, S., Chinn, S., & Burney, P. (2000) · European Respiratory Journal · doi:10.1183/09031936.00.16581700 · Cited by 153
Nebert, D. W., Jorge-Nebert, L. F., & Vesell, E. S. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303060-00002 · Cited by 145
Sulphation deficit in “low-functioning” autistic children: a pilot study
Alberti, A., Pirrone, P. G., Elia, M., Waring, R. H., & Romano, C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00337-0 · Cited by 144
CUMMINGS, A. J., King, M. L., & MARTIN, B. K. (1967) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1967.tb01948.x · Cited by 143
Inter‐subject and ethnic differences in paracetamol metabolism.
Critchley, J., Nimmo, G., Gregson, C., Woolhouse, N., & Prescott, L. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02953.x · Cited by 140
Sulfonation in Pharmacology and Toxicology
Kauffman, F. C. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033496 · Cited by 136
p-Cresol: a toxin revealing many neglected but relevant aspects of uraemic toxicity
Vanholder, R., De Smet, R., & Lesaffer, G. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.12.2813 · Cited by 108
Interactions of the Gut Microflora and the Host in Toxicology
Rowland, I. R. (1988) · Toxicologic Pathology · doi:10.1177/019262338801600207 · Cited by 104
THE ASSOCIATION OF GASTRO‐DUODENAL ULCERATION AND PARKINSON'S DISEASE
Strang, R. R. (1965) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb72277.x · Cited by 94
Ling, W. H., & Hänninen, O. (1992) · Journal of Nutrition · doi:10.1093/jn/122.4.924 · Cited by 93
Burchell, B., & Coughtrie, M. W. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s4739 · Cited by 89
Pharmacogenomics: from bedside to clinical practice
Marsh, S., & McLeod, H. L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl087 · Cited by 88
Thompson, D. C., Perera, K., & London, R. E. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00043a007 · Cited by 87
Pharmacometabonomic Phenotyping Reveals Different Responses to Xenobiotic Intervention in Rats
Li, H., Ni, Y., Su, M., Qiu, Y., Zhou, M., Qiu, M., Zhao, A., Zhao, L., & Jia, W. (2007) · Journal of Proteome Research · doi:10.1021/pr060513q · Cited by 85
Cresol Isomers: Comparison of Toxic Potency in Rat Liver Slices
Thompson, D. C., Perera, K., Fisher, R., et al. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1048 · Cited by 83
The metabolism of drugs by the gut flora
Mikov, M. (1994) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188922 · Cited by 75
Sulfation of minoxidil by liver sulfotransferase
Johnson, G. A., Barsuhn, K., & McCall, J. M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90268-4 · Cited by 69
Mechanism-based inactivation of dopamine .beta.-hydroxylase by p-cresol and related alkylphenols
Goodhart, P. J., DeWolf, W. E., & Kruse, L. I. (1987) · Biochemistry · doi:10.1021/bi00383a025 · Cited by 69
Human cytosolic sulfotransferase SULT1A1
Hempel, N., Gamage, N. U., Martin, J. L., & McManus, M. E. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.002 · Cited by 68
Daly, A. K. (2007) · PubMed · doi:10.25405/ncl.34631064 · Cited by 63
Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool
Ala-Korpela, M. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.6.761 · Cited by 62
Lau, G. S. N., & Critchley, J. (1994) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(94)00859-0 · Cited by 61
Reduction by the gut microflora of animals and man
Rowland, I. R. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90550-2 · Cited by 56
Yan, Z., Zhong, H. M., Maher, N., Torres, R., Leo, G. C., Caldwell, G. W., & Huebert, N. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006387 · Cited by 52
The influence of the gut microflora on food toxicity
Rowland, I. R. (1981) · Proceedings of The Nutrition Society · doi:10.1079/pns19810011 · Cited by 50
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics.
Nebert, D., & Vesell, E. (2006) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.09.008 · Cited by 45
Tanaka, E., Yamazaki, K., & Misawa, S. (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00301.x · Cited by 43
Estimation of phenolic conjugation by colonic mucosa.
Ramakrishna, B., Gee, D., Weiss, A. A., Pannall, P. R., Roberts-Thomson, I. C., & Roediger, W. E. W. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.6.620 · Cited by 43
Metabolism of low-dose paracetamol in patients with chronic neurological disease
Steventon, G. B., Heafield, M. T. E., Waring, R. H., Williams, A. C., Sturman, S., & Green, M. (1990) · Xenobiotica · doi:10.3109/00498259009046818 · Cited by 31
Kim, S. Y., Laxmi, Y. R. S., Suzuki, N., Ogura, K., Watabe, T., Duffel, M. W., & Shibutani, S. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005330 · Cited by 30
p-Cresol Sulfate Is the Dominant Component of Urinary Myelin Basic Protein Like Material
Cao, L., KIRK, M. C., Coward, L. U., Jackson, P. L., & Whitaker, J. N. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1764 · Cited by 29
Effect of toluene and cresols on Na+,K+-ATPase, and serotonin in rat brain
Calderón-Guzmán, D., Hernández-Islas, J. L., Espitia-Vázquez, I., Mejía, G. B., Hernández-García, E., del Angel, D. S., & Olguín, H. J. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.09.005 · Cited by 27
Sivsammye, G., & Sims, H. V. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.8.1851-1853.1990 · Cited by 26
Morinaga, Y., Fuke, C., Arao, T., & Miyazaki, T. (2003) · Legal Medicine · doi:10.1016/j.legalmed.2003.08.005 · Cited by 25
Burchell, B., & Coughtrie, M. W. H. (1997) · Environmental Health Perspectives · doi:10.2307/3433277 · Cited by 25
Thomas, N., & Coughtrie, M. W. H. (2003) · Xenobiotica · doi:10.1080/00498250310001609192 · Cited by 23
Gaikwad, N. W., & Bodell, W. J. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00274-5 · Cited by 22
Voltage-Dependent Inhibition of RCK1 K+ Channels by Phenol, p-Cresol, and Benzyl Alcohol
Elliott, A. A., & Elliott, J. R. (1997) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13489-x · Cited by 19
Influence of Advanced Age on the Formation and Elimination of Acetaminophen Metabolites by Male Rats
Galinsky, R. E., & Corcoran, G. B. (2008) · Pharmacology · doi:10.1159/000138186 · Cited by 17
Fasting Enhances p-Cresol Production in the Rat Intestinal Tract
Kawakami, K., KOJIMA, K., MAKINO, I., Kato, I., & Onoue, M. (2007) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.56.301 · Cited by 16
Metabolism of low-dose paracetamol in patients with rheumatoid arthritis
Bradley, H., Waring, R. H., Emery, P., et al. (1991) · Xenobiotica · doi:10.3109/00498259109039509 · Cited by 15
Pagliarulo, V., Datar, R. H., & Côté, R. J. (2002) · Current Issues in Molecular Biology · doi:10.21775/cimb.004.101 · Cited by 15
HIGH LEVELS OF FAECAL p-CRESOL IN A GROUP OF HYPERACTIVE CHILDREN
Adams, R. F., Murray, K. E., & Earl, J. W. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91603-4 · Cited by 11
Modelling paracetamol urine metabolites
Marel, C. V. D., Anderson, B. J., Tibboel, D., & Holford, N. H. G. (2002) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2002.10271_15.x · Cited by 1
Jackson, P. L., Cao, L., Blalock, J. E., et al. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.005 · Cited by 1
Cited by
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Role of the normal gut microbiota
Jandhyala, S. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i29.8787 · Cited by 3,001
An insight into gut microbiota and its functionalities
Adak, A., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2943-4 · Cited by 1,485
Mapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Chemical transformation of xenobiotics by the human gut microbiota
Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080
Metadata
- Authors
- Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- Pfizer (United States) (US)
- Pfizer (United Kingdom) (GB)
- Corresponding author
- Nicholson, Jeremy K.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-08-25
- Volume
- 106
- Issue
- 34
- Pages
- 14728-14733
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2731842
- OpenAlex
- W2061156796
- Cited by
- 765
- References
- 76
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 31 · 2023: 40 · 2022: 38 · 2021: 51 · 2020: 68 · 2019: 54 · 2018: 38 · 2017: 44 · 2016: 70 · 2015: 54 · 2014: 48 · 2013: 44 · 2012: 53
- FWCI
- 40.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Imperial College London
- King's College London
- Wuhan University
- Medical Research Council
- Royal Holloway, University of London
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- acetaminophen metabolism, gut microbiota, host-microbiome interactions, p-cresyl sulfate, acetaminophen sulfate, acetaminophen glucuronide, personalized medicine, drug metabolism variability
- MeSH terms
- Acetaminophen, Administration, Oral, Adolescent, Adult, Bacteria, Cresols, Humans, Male, Middle Aged, Magnetic Resonance Spectroscopy, Sulfates, Sulfuric Acid Esters, Analgesics, Non-Narcotic, Gastrointestinal Tract, Host-Pathogen Interactions, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.